Cancer-related Fatigue
December 7, 2023
Fatigue is one of the most common symptoms experienced by those living with CLL and SLL, and it is also commonly overlooked,underreported, and undertreated.
Fatigue is one of the most common symptoms experienced by those living with CLL and SLL, and it is also commonly overlooked,underreported, and undertreated.
Chronic lymphocytic leukemia (CLL) is a slow-growing blood cancer involving the abnormal overgrowth of
a type of white blood cell called B-lymphocytes.
Autoimmune hemolytic anemia (AIHA) is the most common autoimmune condition associated with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
Tumor lysis syndrome is a rare condition that can happen due to the rapid death of cancer cells. When the cancer cells are killed, the debris from inside the cells enters the bloodstream.
Education On-Demand Education On-Demand The varied educational activities offered by CLL Society are your opportunities to learn basic information, dive deep into specific topics, or stay abreast of cutting-edge news and
In an early-stage clinical trial, zanubrutinib-sonrotoclax-obinutuzumab was well tolerated and all patients with CLL / SLL responded to treatment.
An ongoing phase 3 study is comparing the efficacy of sonrotoclax plus zanubrutinib with acalabrutinib plus venetoclax in patients with untreated CLL.
2026 Research Program supports studies aimed at overcoming treatment resistance and improving long-term outcomes for CLL and SLL patients
There are multiple excellent choices between limited-duration and continuous targeted therapies that all can offer durable disease control.